Presentation is loading. Please wait.

Presentation is loading. Please wait.

Deferasirox Decreases Liver Iron Concentration in Iron-Overloaded Patients with Myelodysplastic Syndromes, Aplastic Anemia and Other Rare Anemias Acta.

Similar presentations


Presentation on theme: "Deferasirox Decreases Liver Iron Concentration in Iron-Overloaded Patients with Myelodysplastic Syndromes, Aplastic Anemia and Other Rare Anemias Acta."— Presentation transcript:

1 Deferasirox Decreases Liver Iron Concentration in Iron-Overloaded Patients with Myelodysplastic Syndromes, Aplastic Anemia and Other Rare Anemias Acta Haematol 2015;134: DOI: / Fig. 1. Patient disposition. © 2015 S. Karger AG, Basel - CC BY-NC 3.0

2 Deferasirox Decreases Liver Iron Concentration in Iron-Overloaded Patients with Myelodysplastic Syndromes, Aplastic Anemia and Other Rare Anemias Acta Haematol 2015;134: DOI: / Fig. 2. Mean change in LIC and after 1 year (a) and 2 years (b) of treatment, by underlying anemia, in Japanese and non-Japanese patients. © 2015 S. Karger AG, Basel - CC BY-NC 3.0


Download ppt "Deferasirox Decreases Liver Iron Concentration in Iron-Overloaded Patients with Myelodysplastic Syndromes, Aplastic Anemia and Other Rare Anemias Acta."

Similar presentations


Ads by Google